LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Adverum Biotechnologies (NASDAQ: ADVM)

Follow NASDAQ:ADVM Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
04/02/2025
Buy
$4.04
15,209
$61K
2.76M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/31/2025
Buy
$4.38
19,566
$86K
2.74M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/27/2025
Sell
$5.19
16,593
$86K
141,800
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/26/2025
Buy
$5.04
20,407
$103K
125,207
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/20/2025
Buy
$5.61
30,600
$172K
2.72M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/19/2025
Buy
$4.94
25,000
$123K
2.69M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/18/2025
Buy
$4.73
44,341
$210K
2.67M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
03/18/2025
Buy
$4.60
18,000
$83K
2.62M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
02/28/2025
Buy
$4.60
85,068
$391K
2.60M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
02/27/2025
Buy
$4.46
86,802
$387K
2.52M
NASDAQ ADVM Adverum Biotechnologies
Leonard Braden Michael / 10 percent owner
02/26/2025
Buy
$4.01
164,886
$661K
2.43M
NASDAQ ADVM Adverum Biotechnologies
Soparkar Peter / officer: CHIEF OPERATING OFFICER
02/25/2025
Buy
$4.20
78,750
$331K
78,750
NASDAQ ADVM Adverum Biotechnologies
Ozden Rabia Gurses / officer: Chief Medical Officer
02/25/2025
Buy
$4.20
48,750
$205K
48,750
NASDAQ ADVM Adverum Biotechnologies
Seyedkazemi Setareh / officer: CHIEF DEVELOPMENT OFFICER
02/25/2025
Buy
$4.20
48,750
$205K
48,750
NASDAQ ADVM Adverum Biotechnologies
Fischer Laurent / director, officer: CEO, PRESIDENT AND DIRECTOR
02/25/2025
Buy
$4.20
150,000
$630K
150,000
NASDAQ ADVM Adverum Biotechnologies
Rubinstein Linda M / officer: CHIEF FINANCIAL OFFICER
02/25/2025
Buy
$4.20
48,750
$205K
48,750

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous